Medtech

TreeFrog Therapeutics Leases 13,488 Square Feet at Cambridgeport Labs

January 6, 2025

MilliporeSigma to Acquire HUB Organoids Holding B.V., Advancing Next Generation Biology Portfolio

December 18, 2024

Tasca Therapeutics Launches with $52 Million Series A Financing

December 10, 2024

THIS WEEK'S STORIES

NTx Welcomes Accomplished Government Industry Executive William Doak as Vice President of Global Government Programs

January 28, 2025

Fresenius Kabi Receives FDA 510(k) Clearance for Adaptive Nomogram, Enhancing Plasma Collection Efficiency with the Aurora Xi Plasmapheresis System

January 28, 2025

LIB Therapeutics Announces Publication of Phase 3 Study of Lerodalcibep in Homozygous Familial Hypercholesterolemia (HoFH) in Lancet Diabetes & Endocrinology

January 27, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Fresenius Kabi Receives FDA 510(k) Clearance for Adaptive Nomogram, Enhancing Plasma Collection Efficiency with the Aurora Xi Plasmapheresis System

Medimaps Breaks New Ground in Fracture Risk Assessment with FDA Clearance and MDR Certification for TBS Osteo Next Generation Software

Aptyx Amplifies Expertise in Complex Interventional Products With Acquisition of Medical Murray’s North Carolina Facility

Stratasys Launches TrueDent in Europe, Bringing the Benefits of Monolithic Digital Dentures to Dental Labs, Dentists, and Patients

Vetter introduces the next evolution of the V-OVS® syringe closure system

Most Read

Matt Stober Appointed to the Board of GeminiBio

AVS Completes a $36M Series B Financing Ahead of IVL U.S. Commercial Launch

AdvoCare® Welcomes Kathy Blosser as New Vice President of Supply Chain and Operations

Fresenius Kabi Receives FDA 510(k) Clearance for Adaptive Nomogram, Enhancing Plasma Collection Efficiency with the Aurora Xi Plasmapheresis System

EDITOR PICKS

TreeFrog Therapeutics Leases 13,488 Square Feet at Cambridgeport Labs

MilliporeSigma to Acquire HUB Organoids Holding B.V., Advancing Next Generation Biology Portfolio

Tasca Therapeutics Launches with $52 Million Series A Financing

THIS WEEK'S STORIES

NTx Welcomes Accomplished Government Industry Executive William Doak as Vice President of Global Government Programs

Fresenius Kabi Receives FDA 510(k) Clearance for Adaptive Nomogram, Enhancing Plasma Collection Efficiency with the Aurora Xi Plasmapheresis System

LIB Therapeutics Announces Publication of Phase 3 Study of Lerodalcibep in Homozygous Familial Hypercholesterolemia (HoFH) in Lancet Diabetes & Endocrinology

POPULAR CATEGORY

ABOUT US

FOLLOW US